Humoral immunity involves multiple checkpoints during B-cell development, maturation, and activation. The cell death receptor CD95/Fas-mediated apoptosis plays a critical role in eliminating the unwanted activation of B cells by self-reactive antigens and in maintaining B-cell homeostasis through activation-induced B-cell death (AICD). The molecular mechanisms controlling AICD remain largely undefined. Herein, we show that the E3 ubiquitin ligase Hrd1 protected B cells from activation-induced cell death by degrading the death receptor Fas. Hrd1-null B cells exhibited high Fas expression during activation and rapidly underwent Fas-mediated apoptosis, which could be largely inhibited by FasL neutralization. Fas mutation in Hrd1 KO mice abrogated the increase in B-cell AICD. We identified Hrd1 as the first E3 ubiquitin ligase of the death receptor Fas and Hrd1-mediated Fas destruction as a molecular mechanism in regulating B-cell immunity.
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Hrd1 | Fas | B cells | ubiquitination B -cell immunity involves several checkpoints, which are important to orchestrate and balance survival and apoptotic signals and control the quality and size of the B-cell compartment (1, 2) . The earliest steps in B-cell development occur in the bone marrow, where assembly of the pre-B-cell receptor (pre-BCR) followed by the mature BCR occurs in distinct stages. Once the mature BCR is expressed, B lymphocytes then progress into the immature B-cell stage, where further selection checkpoints occur before the immature B cells transition to the periphery and mature into circulating B cells (2, 3) . Mature B cells are maintained through tonic BCR, CD40, and B-cell-activating factor receptor (BAFFR) signaling (4). Activation by cross-linking the BCR leads to rapid proliferation, somatic hypermutation, and further differentiation of B cells (5, 6) . The expansion of activated B-cell compartment is subsequently downmodulated through activation-induced cell death (AICD) (7, 8) .
The death receptor Fas has been identified as a key regulator of AICD of B cells (9) (10) (11) . Fas is highly expressed on activated B cells, particularly in the germinal center, where it mediates the deletion of autoreactive or unproductive somatic hypermutated B cells (12) (13) (14) . Fas, as well as its ligand FasL, play critical roles in B-cell apoptosis. The selective removal of Fas from activated B cells results in lupus-like disease and autoantibody production (15) (16) (17) . It has been a widely accepted view that the Fas/FasL mutations result in, at least in part, a failure to eliminate self-reactive GC B cells in autoimmune patients and animal models (12, 18) . However, more recent studies show that FAS is in fact not required for the elimination of self-reactive GC B cells. Instead, Fas inactivation led to accumulation of a population of unconventional GC B cells that underwent somatic hypermutation and survived despite losing antigen reactivity (8) . Nevertheless, it is clear that Fasmediated B-cell death is critically involved in B-cell-mediated autoimmune diseases. However, the molecular mechanisms underlying how Fas-mediated B-cell death is regulated remain an enigma.
Hrd1 is one of the ER-associated E3 ubiquitin ligases involved in ERAD (endoplasmic reticulum-associated degradation), which is situated in the ER along with Sel1, Derlin1, Herp, and other proteins as part of an ERAD complex (19, 20) . During ERAD, misfolded proteins within the ER bind to chaperones such as BiP and are retrotranslocated into the cytosol to be ubiquitinated by the cytosolic RING (really interesting new gene) domain of Hrd1 (19) . Whereas Hrd1 is required for the clearance of misfolded proteins during ERAD, emerging evidence suggests that Hrd1 can also regulate cellular functions by controlling the availability of specific proteins, such as Nrf2, Blimp1, and PGC-1β (21) (22) (23) . In this paper, we report that Hrd1 plays a crucial role at the B-cell survival checkpoint by degrading the death receptor Fas during peripheral B-cell activation to downmodulate AICD.
Significance
Endoplasmic reticulum (ER)-associated degradation (ERAD) mediated by the E3 ubiquitin ligase Hrd1 controls ER stress through clearance of misfolded proteins. However, the physiological roles-in particular, the cell-and organ-specific functions of Hrd1 ERAD-remain undefined. Here we demonstrate that Hrd1 ERAD governs a critical checkpoint of B-cell immunity via controlling the activation-induced apoptosis of B cells. At the molecular level, Hrd1 functions as an ubiquitin ligase for the death receptor CD95/Fas. Given the fact of the ubiquitous roles of Fas in cell death and the ubiquitous expression of the antiapoptotic ubiquitin ligase Hrd1, Hrd1-mediated Fas degradation is likely a common biological mechanism in regulating Fas-induced cell death. ) were crossed with mice expressing CD19 promoter-driven Cre recombinase (CD19-Cre) to generate mice with a conditional B-cell-specific deletion of Hrd1. Real-time RT-PCR analysis detected a more than 90% reduction in Hrd1 expression in B cells from Hrd1 KO mice (SI Appendix, Fig. S1B ), which was further confirmed at the protein level as determined by Western blotting (SI Appendix, Fig. S1C ). B-cell development appears to be normal because both the percentages and the absolute cell numbers of the B220 + IgM − pro/pre-B cells and B220 low IgM + immature B cells are comparable between WT and Hrd1 KO mice ( Fig. 1 A-C) . However, deletion of Hrd1 resulted in significantly reduced number of B220 HI IgM + circulating mature B cells in the bone marrow ( Fig. 1 A-C) . Consequently, peripheral B220 + cells were reduced in the spleen (Fig. 1 D and F Fig. S1 H-J) . Therefore, loss of Hrd1 in CD19-expressing cells resulted in loss of mature B cells and particularly affected mature follicular B2 cells in the periphery.
When stimulated with the antigenic stimuli α-IgM F(ab) 2 or the addition of α-CD40 F(ab) 2 , WT and Hrd1 KO B cells proliferated at similar rates ( Fig. 1 G and H) , suggesting that Hrd1 is dispensable for B-cell proliferation upon in vitro stimulation. We then investigated if the reduction in peripheral B cells in Hrd1 KO mice was caused by increased apoptosis of B cells. Low frequencies of apoptotic cells as detected by AnnexinV and PI staining were found among freshly isolated splenic B cells from Hrd1 KO mice ( Fig. 1 I and J) . However, upon stimulation of BCR, CD40 costimulator, or Toll-like receptor (TLR4), we detected significantly increased apoptosis among activated B cells from Hrd1 KO mice ( When examining the splenocytes of immunized Hrd1 KO mice, we detected a significant increase in Fas expression on B cells in the spleen of mice immunized with either TI or TD antigens ( Fig. 3 A and B) . Importantly, the mean fluorescence identity (MFI) of Fas expression on the surface of Hrd1 KO B cells was significantly increased ( (Fig. 3H ). Therefore, Hrd1 appears to protect B cell from activation-induced cell death from downregulating Fas at the posttranscriptional level.
Consistent with increased Fas expression, treatment of LPSstimulated B cells with agonistic Fas antibody resulted in increased apoptosis in Hrd1 KO B cells (Fig. 3 I and J) , demonstrating that increased Fas expression in Hrd1 KO B cells sensitizes the cells to Fas-mediated apoptosis. To further support this conclusion, we observed that neutralization of the FasL significantly inhibited both WT and Hrd1 KO B-cell death upon LPS stimulation (SI Appendix, Fig. S3 C and D) . Fas signaling leads to recruitment of FADD (Fas-associated protein with Error bars represent SEM. For A and B, n = 9. For C-H, n = 5. *P < 0.05, **P < 0.01, ***P < 0.001. The relative levels of cleaved caspase 8 and 3 from four independent experiments are shown. Error bars represent SEM. For A and B, n = 5. For C-H, n = 7. *P < 0.05, **P < 0.01, ***P < 0.001.
death domain) and cleavage of caspase-8, which then induces cleavage of proapoptotic caspase-3 (25) . As expected, whereas addition of agonistic Fas antibody increased caspase-8 and caspase-3 cleavage in both WT and Hrd1 KO B cells, the levels of cleaved caspase-8 and caspase-3 were consistently higher in Hrd1 KO B cells, with LPS stimulation alone, or with LPS and anti-Fas antibody ( Fig. 3 K and L) . Thus, increased AICD in Hrd1 KO B cells is due to increased Fas expression and sensitization to Fas-mediated apoptosis.
Hrd1 Inhibits the Activation-Induced B-Cell Apoptosis Independent of ER Stress. Hrd1 has been shown to protect against ER-stressinduced apoptosis through destructing the misfolded proteins (26, 27) . To determine the contribution of UPR (unfolded protein response)-induced apoptosis in Hrd1 KO peripheral B cells, we examined the induction of ER-stress target genes. Whereas LPS stimulation induced expression of the ER-stress-related genes Xbp1s, Bip, Chop, Erdj3, and Wsj4, we did not detect a significant difference in their expression levels between WT and Hrd1 KO B cells (SI Appendix, Fig. S4 A-E), implying that Hrd1 gene deletion unlikely resulted in the accumulation of misfolded/ unfolded protein under the physiological condition. To further validate this conclusion, we demonstrated that further deletion of the UPR-induced proapoptotic protein CHOP did not rescue the reduction in the B cells in spleen of Hrd1 KO mice (SI Appendix, Fig. S5 A and B) . Hrd1 Is a Fas Ubiquitin Ligase in B Cells. Because loss of Hrd1 expression resulted in the increased Fas protein expression, we speculated that Hrd1 functions as an E3 ubiquitin ligase to control Fas protein expression in B cells. In support of this hypothesis, we detected Hrd1 interaction with Fas in transiently transfected HEK293 cells (Fig. 4A) . The interaction between endogenous Hrd1 and Fas was confirmed with coimmunoprecipitation of Hrd1 and Fas in A20 mature B cells (Fig. 4B) . Furthermore, cotransfection of Flag-tagged Fas with full-length (FL) or truncated mutants of Hrd1 revealed that the cytoplasmic C terminus of Hrd1 is required and sufficient for its interaction with Fas (Fig. 4C) , indicating that Hrd1 interacts with Fas Hrd1 expression was confirmed by Western blotting (H). The Fas expression was determined by flow cytometry, and data shown are the average percentages from four independent experiments (I, P < 0.001).
The mRNA levels of Fas and Hrd1 in Hrd1 knockdown and control A20 cells were determined by real-time PCR (J). Error bars represent SEM. n = 11. *P < 0.05, **P < 0.01, ***P < 0.001. IB, immunoblotting; IP, immunoprecipitation; WCL, whole cell lysate.
through its cytoplasmic region. As E3 ligase often catalyzes the ubiquitin-conjugation to its interaction proteins, we then asked whether Hrd1 is an E3 ubiquitin ligase for Fas. As indicated in Fig. 4D , expression of Hrd1, but not its E3 ligase-inactive CA mutant, dramatically enhanced Fas ubiquitin conjugation. To further investigate whether Hrd1 ubiquitinates Fas under physiological conditions, we stimulated WT and Hrd1 KO B cells with LPS and immunoprecipitated the endogenous Fas receptor. Consistent with our in vitro results, we detected reduced levels of ubiquitination of Fas in LPS-stimulated Hrd1 KO B cells compared with WT cells, even though a higher amount of Fas was immunoprecipitated from Hrd1 KO B-cell lysates (Fig. 4E) . Moreover, the reduction of Fas ubiquitination in Hrd1 KO B cells correlated with reduced Fas protein degradation, as LPSstimulated Hrd1 KO B cells showed increased and more stable surface expression of Fas at 0, 1, 2, and 4 h after CHX treatment (Fig. 4 F and G) . Taken together, our data indicate that Hrd1 recruits Fas protein through its cytoplasmic C terminus to catalyze Fas for ubiquitination and degradation. Therefore, Fas is a target of Hrd1 E3 ubiquitin ligase activity, and the loss of Hrd1 leads to stabilization and increased expression of Fas. The DNA recombinase expression driven under the CD19 promoter mediates deletion of floxed gene during the pro-B stage of B-cell development, raising a possibility that the elevated Fas expression in mature B cells from Hrd1 KO mice could be a consequence of B-cell developmental defect. To test this, we used a Hrd1-specific shRNA knockdown approach to inhibit Hrd1 expression in a human B-cell line, A20. Hrd1-specific shRNA expression resulted in an about 90% reduction in Hrd1 protein and its mRNA expression (Fig. 4 H and J) . Of note, suppression of Hrd1 expression resulted in a significant increase in Fas + A20 cells without affecting Fas mRNA expression (Fig. 4  I and J) , clearly indicating that Hrd1 regulates Fas protein degradation in a cell-autonomous manner.
Deficient Fas Signaling in MRL/lpr Mice Abrogates Increased AICD in Hrd1 KO Mice. To confirm that Hrd1 protects B cells from AICD through degradation of Fas, we generated Fas-deficient Hrd1 KO (DKO) mice by crossing MRL/lpr Fas mutant mice (Fas KO) with B-cell-specific Hrd1 KO mice (Hrd1 f/f CD19-Cre + Fas lpr/lpr ). Mice at the mixed genetic background were used, and littermates were used as controls. Defective Fas signaling in MRL/lpr mice has been reported to lead to splenomegaly and lymphadenopathy (29) . Indeed, we observed that Fas KO mice at 8-16 wk of age exhibited splenomegaly, and, notably, further deletion of Hrd1 failed to alter this splenomegaly phenotype, as both the spleen sizes and total splenocyte numbers were comparable between Fas KO and DKO mice ( Fig. 5 A and B) . In contrast to the significant reduction in B-cell numbers in Hrd1 KO mice compared with WT mice, the CD3 −
B220
+ B cells in Fas KO and DKO spleens were comparable, suggesting that the reduced B-cell phenotype is abrogated in DKO mice ( Fig. 5 C and D) . Surprisingly, Hrd1 deletion in CD19
+ cells in Fas KO mice led to a dramatic reduction in CD3 low B220 + T cells (29) (Fig. 5C ), suggesting that, in contrast to a Fas-dependent role of Hrd1 in B cells, Hrd1 appears to regulate CD3 low B220 + T cells in a Fas-independent manner. Consistent with our hypothesis that Hrd1 protects B cells from Fas-mediated AICD, upon stimulation, Hrd1 KO B cells underwent higher rates of apoptosis, but Fas KO and DKO B cells exhibited similar rates of apoptosis as WT B cells (Fig. 5 E and  F) . Moreover, loss of Fas-mediated apoptosis led to expansion of autoreactive B cells and increased autoantibody production in Fas KO mice (29) . As expected, Fas KO mice had increased antinuclear antibodies (ANA), and DKO mice had similarly increased levels of ANA (Fig. 5 F and G) , indicating that Hrd1-mediated Fas ubiquitination is important for elimination of selfreactive B cells. Of note, in contrast to the similar anti-ANA levels in Fas KO and DKO mice, lymphocyte infiltration in both the liver and kidney was partially attenuated by B-cell-specific Hrd1 deletion (Fig. 5 H and I) . Thus, these DKO studies indicate that Hrd1 protects against apoptosis through degradation of Fas. Because Fas-mediated cell death is a crucial mechanism in various physiological processes, such as AICD and autoimmunity, our identification of Hrd1 as a regulator of Fas stability could provide insight for a wide variety of biological applications.
Discussion
Here we report that Hrd1 is required for protecting mature B-cell population from the activation-induced apoptosis through degradation of the death receptor Fas/CD95. This conclusion is validated by the following observations: (i) Conditional deletion of Hrd1 specifically in B-cell lineage results in reduced mature B cells in the peripheral lymphoid organs; (ii) Hrd1-deficiency sensitizes Fas-mediated activation-induced B-cell death, which can be largely Error bars represent SEM. ns, not significant. n = 7. *P < 0.05, **P < 0.01, ***P < 0.001.
blocked by FasL neutralization; (iii) Hrd1 inhibits per cell-based Fas protein but not mRNA expression in B cells; (iv) Hrd1 catalyzes Fas ubiquitination and promotes Fas protein degradation in B cells; and (v) Hrd1 regulates B-cell autoimmune response in a Fasdependent manner in the lupus-prion MRL/lpr mice. Hrd1 functions as a critical regulator in protecting B cells from AICD, based on our observation that apoptosis in Hrd1 KO peripheral B cells upon antigenic stimulation was significantly increased. Fas was up-regulated at both the mRNA and protein level, initially suggesting that Fas expression might be indirectly induced upon increase of Hrd1 substrates, such as p53 or IRE1α (27, 30) . However, we did not detect a significant increase in the p53-target genes PUMA and p21 in activated Hrd1 KO peripheral B cells compared with WT. In addition, although we observed increased apoptosis with either antigenic stimuli or ER stress induced by tunicamycin, we found that Hrd1 KO peripheral B cells increased Fas expression upon antigenic stimulation, but not upon increased ER stress. Indeed, deletion of the UPR targets IRE1α and CHOP did not abrogate increased Fas expression or rescue the increased susceptibility to apoptosis of Hrd1 KO B cells, suggesting that up-regulation of Fas in activated Hrd1 KO B cells is unlikely to be caused by increased ER stress or p53 activation. The fact that per-cell Fas protein levels (MFI) but not mRNA expression levels were increased in Hrd1-null B cells during activation indicates that Hrd1 suppresses B-cell apoptosis through destruction of Fas protein. Indeed, we found that Hrd1 interacts directly with Fas protein, and loss of Hrd1 in B cells leads to decreased Fas ubiquitination, resulting in increased Fas protein stability upon antigenic stimulation.
Hrd1 regulates the B-cell immune response largely through the death receptor Fas-dependent manner. When cultured with LPS, both lpr (Fas KO) and Fas/Hrd1 double KO B cells had comparable apoptosis, indicating that Fas deficiency abrogated the proapoptotic phenotype induced by Hrd1 deletion. As a result, Fas KO and Fas/Hrd1 KO mice had similar B-cell numbers and comparable ANA levels. These discoveries provide a proofof-principle for the Fas-dependent role of Hrd1 in AICD. However, while not largely abolished, lymphocyte infiltration was significantly reduced by further Hrd1 deletion in Fas KO mice. This reduction is unlikely due to the changes in autoantibody production, because the ANA levels were comparable between Fas KO and DKO mice. Interestingly, this reduction in lymphocyte infiltration was associated with a decrease in CD3 low B220
+ cells, which are derived from thymus. Recent studies suggest that the CD3 low B220
+ cells in lpr mice are innate lymphoid cells and play important roles in organ inflammation (31) . It will be interesting to further study how Hrd1 regulates the development of CD3 low B220 + cells independent of Fas destruction.
Experimental Procedures
Animals. Animal strains are detailed in SI Appendix. All mice used in this study were maintained and used at the Northwestern University Mouse Facility under pathogen-free conditions according to institutional guidelines. All of the animal studies including antigen immunization and collecting of the lymphoid organs have been approved by the Institutional Animal Care and Use Committee of Northwestern University. No human study is involved.
Primary B-Cell Isolation and Culture. Primary B cells were negatively or positively isolated from 8-to 12-wk-old mice. Purified B cells were stimulated with goat F(ab)2 anti-mouse IgM (10 mg/mL; Jackson Immunoresearch), anti-CD40 (1 mg/mL; eBioscience), LPS (500 ng/mL), and tunicamycin as indicated. Cell proliferation and death were determined as detailed in SI Appendix.
Immunizations. The antigen-specific B-cell immune response of WT and Hrd1 KO mice was analyzed as detailed in SI Appendix.
